Applications of the Keap1-Nrf2 system for gene and cell therapy

Katja M Kanninen1, Yuriy Pomeshchik1, Hanna Leinonen2

  • 1Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Finland.

Insights

Oxidative stress contributes to various diseases. Gene therapy targeting the Nrf2 pathway offers potential treatments for neurological disorders and cancer by modulating its activity.

Area of Science:

  • Biochemistry and Molecular Biology
  • Neuroscience
  • Oncology

Background:

  • Oxidative stress is implicated in acute and chronic diseases, including central nervous system injuries, neurodegenerative disorders, cardiovascular diseases, and cancer.
  • The transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2) is a key regulator of cellular defense against oxidative stress.
  • While Nrf2 activation provides cytoprotection, its dysregulation in cancer promotes tumor growth by upregulating protective genes.

Purpose of the Study:

  • To review preclinical gene therapy strategies aimed at modulating Nrf2 activity.
  • To highlight the therapeutic potential of targeting Nrf2 in neurological diseases and cancer.
  • To discuss the role of Nrf2 in stem cell therapy for neurological disorders.

Main Methods:

  • Review of current preclinical research on gene therapy approaches for Nrf2 modulation.
  • Analysis of studies investigating Nrf2's role in cancer cell proliferation and survival.
  • Examination of Nrf2's involvement in stem cell-based therapies for neurological conditions.

Main Results:

  • Preclinical gene therapy approaches are being developed to either enhance or suppress Nrf2 activity.
  • Targeting Nrf2 holds promise for treating both neurological diseases and various cancers.
  • Nrf2 plays a significant role in the efficacy of stem cell therapies for neurological disorders.

Conclusions:

  • Modulating Nrf2 activity through gene therapy represents a promising therapeutic avenue for oxidative stress-related diseases.
  • Further research into Nrf2-targeted therapies is warranted for neurological conditions and cancer treatment.
  • Understanding Nrf2's function is crucial for advancing stem cell therapy in neurodegenerative disorders.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.4K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K